U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C19H21ClFN3O3.ClH
Molecular Weight 430.301
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BESIFLOXACIN HYDROCHLORIDE

SMILES

Cl.N[C@@H]1CCCCN(C1)C2=C(F)C=C3C(=O)C(=CN(C4CC4)C3=C2Cl)C(O)=O

InChI

InChIKey=PMQBICKXAAKXAY-HNCPQSOCSA-N
InChI=1S/C19H21ClFN3O3.ClH/c20-15-16-12(18(25)13(19(26)27)9-24(16)11-4-5-11)7-14(21)17(15)23-6-2-1-3-10(22)8-23;/h7,9-11H,1-6,8,22H2,(H,26,27);1H/t10-;/m1./s1

HIDE SMILES / InChI

Approval Year

Unknown
86413
Name Type Language
BESIFLOXACIN HYDROCHLORIDE
MART.   MI   ORANGE BOOK   USAN   VANDF   WHO-DD  
USAN  
Official Name English
SS734
Code English
BESIFLOXACIN HCL
Common Name English
BESIFLOXACIN HYDROCHLORIDE [ORANGE BOOK]
Common Name English
3-QUINOLINECARBOXYLIC ACID, 7-((3R)-3-AMINOHEXAHYDRO-1H-AZEPIN-1-YL)-8-CHLORO-1-CYCLOPROPYL-6-FLUORO-1,4-DIHYDRO-4-OXO-, MONOHYDROCHLORIDE
Common Name English
Besifloxacin hydrochloride [WHO-DD]
Common Name English
BESIFLOXACIN HYDROCHLORIDE [MI]
Common Name English
BESIVANCE
Brand Name English
BOL-303224-A
Code English
SS-734
Code English
BESIFLOXACIN (AS HYDROCHLORIDE)
Common Name English
(+)-7-((3R)-3-AMINOHEXAHYDRO-1H-AZEPIN-1-YL)-8-CHLORO-1-CYCLOPROPYL-6-FLUORO-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID HYDROCHLORIDE
Systematic Name English
BESIFLOXACIN HYDROCHLORIDE [USAN]
Common Name English
BESIFLOXACIN HYDROCHLORIDE [VANDF]
Common Name English
BESIFLOXACIN HYDROCHLORIDE [MART.]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C795
Created by admin on Fri Dec 15 15:30:15 UTC 2023 , Edited by admin on Fri Dec 15 15:30:15 UTC 2023
Code System Code Type Description
MERCK INDEX
m2448
Created by admin on Fri Dec 15 15:30:15 UTC 2023 , Edited by admin on Fri Dec 15 15:30:15 UTC 2023
PRIMARY Merck Index
SMS_ID
100000143395
Created by admin on Fri Dec 15 15:30:15 UTC 2023 , Edited by admin on Fri Dec 15 15:30:15 UTC 2023
PRIMARY
NCI_THESAURUS
C76228
Created by admin on Fri Dec 15 15:30:15 UTC 2023 , Edited by admin on Fri Dec 15 15:30:15 UTC 2023
PRIMARY
USAN
TT-06
Created by admin on Fri Dec 15 15:30:15 UTC 2023 , Edited by admin on Fri Dec 15 15:30:15 UTC 2023
PRIMARY
CAS
405165-61-9
Created by admin on Fri Dec 15 15:30:15 UTC 2023 , Edited by admin on Fri Dec 15 15:30:15 UTC 2023
PRIMARY
DRUG BANK
DBSALT000018
Created by admin on Fri Dec 15 15:30:15 UTC 2023 , Edited by admin on Fri Dec 15 15:30:15 UTC 2023
PRIMARY
ChEMBL
CHEMBL1201760
Created by admin on Fri Dec 15 15:30:15 UTC 2023 , Edited by admin on Fri Dec 15 15:30:15 UTC 2023
PRIMARY
EPA CompTox
DTXSID20193529
Created by admin on Fri Dec 15 15:30:15 UTC 2023 , Edited by admin on Fri Dec 15 15:30:15 UTC 2023
PRIMARY
PUBCHEM
10224595
Created by admin on Fri Dec 15 15:30:15 UTC 2023 , Edited by admin on Fri Dec 15 15:30:15 UTC 2023
PRIMARY
FDA UNII
7506A6J57T
Created by admin on Fri Dec 15 15:30:15 UTC 2023 , Edited by admin on Fri Dec 15 15:30:15 UTC 2023
PRIMARY
EVMPD
SUB120189
Created by admin on Fri Dec 15 15:30:15 UTC 2023 , Edited by admin on Fri Dec 15 15:30:15 UTC 2023
PRIMARY
ACTIVE MOIETY
Structure of BESIFLOXACIN
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966